• 제목/요약/키워드: vivax malaria

검색결과 116건 처리시간 0.03초

Population Genetics of Plasmodium vivax in Four High Malaria Endemic Areas in Thailand

  • Congpuong, Kanungnit;Ubalee, Ratawan
    • Parasites, Hosts and Diseases
    • /
    • 제55권5호
    • /
    • pp.465-472
    • /
    • 2017
  • Recent trends of malaria in Thailand illustrate an increasing proportion of Plasmodium vivax, indicating the importance of P. vivax as a major causative agent of malaria. P. vivax malaria is usually considered a benign disease so the knowledge of this parasite has been limited, especially the genetic diversity and genetic structure of isolates from different endemic areas. The aim of this study was to examine the population genetics and structure of P. vivax isolates from 4 provinces with different malaria endemic settings in Thailand using 6 microsatellite markers. Total 234 blood samples from P. vivax mono-infected patients were collected. Strong genetic diversity was observed across all study sites; the expected heterozygosity values ranged from 0.5871 to 0.9033. Genetic variability in this study divided P. vivax population into 3 clusters; first was P. vivax isolates from Mae Hong Son and Kanchanaburi Provinces located on the western part of Thailand; second, Yala isolates from the south; and third, Chanthaburi isolates from the east. P. vivax isolates from patients having parasite clearance time (PCT) longer than 24 hr after the first dose of chloroquine treatment had higher diversity when compared with those having PCT within 24 hr. This study revealed a clear evidence of different population structure of P. vivax from different malaria endemic areas of Thailand. The findings provide beneficial information to malaria control programme as it is a useful tool to track the source of infections and current malaria control efforts.

Unstable vivax malaria in Korea

  • Ree, Han-Il
    • Parasites, Hosts and Diseases
    • /
    • 제38권3호
    • /
    • pp.119-138
    • /
    • 2000
  • Korean vivax malaria had been prevalent for longtime throughout the country with low endemicity. As a result of the Korean war (1950-1953), malaria became epidemic. In 1959-1969 when the National Malaria Eradication Service (NMES) was implemented, malaria rates declined, with low endemicity in the south-west and south plain areas and high endemic foci in north Kyongsangbuk-do (province) and north and east Kyonggi-do. NMES activities greatly contributed in accelerating the control and later eradication of malaria. The Republic of Korea (South Korea) was designated malaria free in 1979. However, malaria re-emerged in 1993 and an outbreak occurred in north Kyonggi-do and north-west Kangwon-do (in and/or near the Demilitarized Zone, DMZ) , bordering North Korea. It has been postulated that most of the malaria cases resulted from bites of sporozoite-infected females of An. sinensis dispersed from North Korea across the DMZ. Judging from epidemiological and socio-ecological factors, vivax malaria would not be possible to be endemic in South Korea. Historical data show that vivax malaria in Korea is a typical unstable malaria. Epidemics may occur when environmental, socio-economical, and/or political factors change in favor to malaria transmission, and when such factors change to normal conditions malaria rates become low and may disappear. Passive case detection is a most feasible and recommendable control measure against the unstable vivax malaria in Korea in cost-effect point of view.

  • PDF

Primaquine Administration after Falciparum Malaria Treatment in Malaria Hypoendemic Areas with High Incidence of Falciparum and Vivax Mixed Infection: Pros and Cons

  • Wilairatana, Polrat;Tangpukdee, Noppadon;Kano, Shigeyuki;Krudsood, Srivicha
    • Parasites, Hosts and Diseases
    • /
    • 제48권2호
    • /
    • pp.175-177
    • /
    • 2010
  • Mixed infections of Plasmodium falciparum and Plasmodium vivax is high (~ 30%) in some malaria hypoendemic areas where the patients present with P. falciparum malaria diagnosed by microscopy. Conventional treatment of P. falciparum with concurrent chloroquine and 14 days of primaquine for all falciparum malaria patients may be useful in areas where mixed falciparum and vivax infections are high and common and also with mild or moderate G6PD deficiency in the population even with or without subpatent vivax mixed infection. It will be possibly cost-effective to reduce subsequent vivax illness if the patients have mixed vivax infection. Further study to prove this hypothesis may be warranted.

Therapeutic Assessment of Primaquine for Radical Cure of Plasmodium vivax Malaria at Primary and Tertiary Care Centres in Southwestern India

  • Kumar, Rishikesh;Guddattu, Vasudeva;Saravu, Kavitha
    • Parasites, Hosts and Diseases
    • /
    • 제54권6호
    • /
    • pp.733-742
    • /
    • 2016
  • Acquaintance is scanty on primaquine (PQ) efficacy and Plasmodium vivax recurrence in Udupi district, Karnataka, India. We assessed the efficacy of 14 days PQ regimen (0.25 mg/kg/day) to prevent P. vivax recurrence. Microscopically, aparasitemic adults (${\geq}18years$) after acute vivax malaria on day 28 were re-enrolled into 15 months' long follow-up study. A peripheral blood smear examination was performed with participants at every 1-2 month interval. A nested PCR test was performed to confirm the mono-infection with P. vivax. Of 114 participants, 28 (24.6%) recurred subsequently. The median (IQR) duration of the first recurrence was 3.1 (2.2-5.8) months which ranged from 1.2 to 15.1 months, including initial 28 days. Participants with history of vivax malaria had significantly higher risk of recurrence, with hazard ratio (HR) (95% CI) of 2.62 (1.24-5.54) (P=0.012). Severity of disease (11.4%, 13/114) was not associated (P=1.00) with recurrence. Of 28 recurrence cases, the nPCR proved that P. vivax mono-infection recurrence rate was at least 72.7% (16/22) at first recurrence. In Udupi district, PQ dose of 0.25 mg/kg/day over 14 days seems inadequate to prevent recurrence in substantial proportion of vivax malaria. Patients with a history of vivax malaria are at high risk of recurrences.

Proteomic Analysis of Haptoglobin and Amyloid A Protein Levels in Patients with Vivax Malaria

  • Bahk, Young-Yil;Na, Byoung-Kuk;Cho, Shin-Hyeong;Kim, Jung-Yeon;Lim, Kook-Jin;Kim, Tong-Soo
    • Parasites, Hosts and Diseases
    • /
    • 제48권3호
    • /
    • pp.203-211
    • /
    • 2010
  • Advancements in the field of proteomics have provided great opportunities for the development of diagnostic and therapeutic tools against human diseases. In this study, we analyzed haptoglobin and amyloid A protein levels of vivax malaria patients with combinations of depletion of the abundant plasma proteins, 2-dimensional gel electrophoresis (2-DE), image analysis, and mass spectrometry in the plasma between normal healthy donors and vivax malaria patients. The results showed that the expression level of haptoglobin had become significantly lower or undetectable in the plasma of vivax malaria patients due to proteolytic cleavage when compared to healthy donors on 2-DE gels. Meanwhile, serum amyloid A protein was significantly increased in vivax malaria patient's plasma with high statistical values. These 2 proteins are common acute phase reactants and further large scale evaluation with a larger number of patient's will be necessary to establish the possible clinical meaning of the existential changes of these proteins in vivax malaria patients. However, our proteomic analysis suggests the feasible values of some plasma proteins, such as haptoglobin and serum amyloid A, as associating factor candidates for vivax malaria.

A case of symptomatic splenic infarction in vivax malaria

  • Kim, A-Reum;Park, Yun-Kyu;Lee, Jin-Soo;Chung, Moon-Hyun;Kim, Eun-Sil
    • Parasites, Hosts and Diseases
    • /
    • 제45권1호
    • /
    • pp.55-58
    • /
    • 2007
  • Splenic infarction is a rare complication in malaria cases, and is caused primarily by Plasmodium falciparum. Recently in South Korea, only P. vivax has prevailed since 1993. Although the probability that symptomatic splenic infarction may occur in vivax malaria cases is considered relatively high, there have never been any case reports describing the occurrence of symptomatic splenic infarction in cases of vivax malaria. A 34-year-old man presented with fever that had persisted for 5 days. P. vivax infection was verified using a peripheral blood smear, and chloroquine was utilized to treat the fever successfully. Six days later, the patient developed pain in the left upper abdomen, which was diagnosed as splenic infarction by computed tomography.

Awareness and Opinions of Inhabitants on Vivax Malaria in Two Endemic Areas, Gyeonggi-do, Korea

  • Bahk, Young Yil;Cho, Shin-Hyeong;Na, Byoung-Kuk;Hong, Sung Jong;Lee, Sung-Keun;Kim, Tong-Soo
    • Parasites, Hosts and Diseases
    • /
    • 제59권5호
    • /
    • pp.513-518
    • /
    • 2021
  • The incidence of vivax malaria in Korea was reduced to a low plateau. For successful elimination of vivax malaria, socio-behavioral changes in the communities are essential. This study aimed to figure out awareness of the inhabitants on the vivax malaria endemicity. The 407 participants including vivax malaria patients and uninfected inhabitants in Gimpo- and Paju-si, Gyeonggi-do, known as high-risk areas in Korea. We used a community-based study design and non-probability sampling method using primary data. Except for the perception about the public health facilities' capability to cope with anti-malaria programs, the 2 groups of participants shared the same level of awareness about public promotional and educational measures and opinions for malaria elimination from the community. Thus, our future goals for malaria prevention and elimination are to develop more active and well-organized community-based education and evaluation programs collaborating with the community healthcare authorities and local governments.

Evaluation of Rapid Diagnostics for Plasmodium falciparum and P. vivax in Mae Sot Malaria Endemic Area, Thailand

  • Chaijaroenkul, Wanna;Wongchai, Thanee;Ruangweerayut, Ronnatrai;Na-Bangchang, Kesara
    • Parasites, Hosts and Diseases
    • /
    • 제49권1호
    • /
    • pp.33-38
    • /
    • 2011
  • Prompt and accurate diagnosis of malaria is the key to prevent disease morbidity and mortality. This study was carried out to evaluate diagnostic performance of 3 commercial rapid detection tests (RDTs), i.e., Malaria Antigen Pf/Pan$^{TM}$, Malaria Ag-Pf$^{TM}$, and Malaria Ag-Pv$^{TM}$ tests, in comparison with the microscopic and PCR methods. A total of 460 blood samples microscopically positive for Plasmodium falciparum (211 samples), P. vivax (218), mixed with P. falciparum and P. vivax (30), or P. ovale (1), and 124 samples of healthy subjects or patients with other fever-related infections, were collected. The sensitivities of Malaria Ag-Pf$^{TM}$ and Malaria Antigen Pf/Pan$^{TM}$ compared with the microscopic method for P. falciparum or P. vivax detection were 97.6% and 99.0%, or 98.6% and 99.0%, respectively. The specificities of Malaria Ag-Pf$^{TM}$, Malaria Ag-Pv$^{TM}$, and Malaria Antigen Pf/Pan$^{TM}$ were 93.3%,98.8%, and 94.4%, respectively. The sensitivities of Malaria Ag-Pf$^{TM}$, Malaria Antigen Pf/Pan$^{TM}$, and microscopic method, when PCR was used as a reference method for P. falciparum or P. vivax detection were 91.8%, 100%, and 96.7%, or 91.9%,92.6%, and 97.3%, respectively. The specificities of Malaria Ag-Pf$^{TM}$, Malaria Ag-Pv$^{TM}$, Malaria Antigen Pf/Pan$^{TM}$, and microscopic method were 66.2%, 92.7%, 73.9%, and 78.2%, respectively. Results indicated that the diagnostic performances of all the commercial RDTs are satisfactory for application to malaria diagnosis.

Western blot diagnosis of vivax malaria with multiple stage-specific antigens of the parasite

  • Son, Eui-Sun;Kim, Tong-Soo;Nam, Ho-Woo
    • Parasites, Hosts and Diseases
    • /
    • 제39권2호
    • /
    • pp.171-176
    • /
    • 2001
  • Western blot analysis was performed to diagnose vivax malaria using stage-specific recombinant antigens. Genomic DNA from the whole blood of a malaria patient was used as templates to amplify the coding regions for the antigenic domains of circumsporozoite protein (CSP-1), meroxoite surface protein (MSP-1), apical merozoite antigen (AMA- 1), serine repeat antigen (SERA), and exported antigen (EXP- 1) of Plasmodium vivax. Each amplified DNA fragment was inserted into a pGEX-4T plasmid to induce the expression of GST fusion protein in Escherichia coli by IPTG. The bacterial cell extracts were separated on 10% SDS-PAGE followed by western blot analysis with patient sera which was confirmed by blood smear examination. When applied with patient sera, 147 (91.9%) out of 160 vivax malaria, 12 (92.3%) out of 13 falciparum malaria, and all 9 vivax/falciparum mixed malaria reacted with at least one antigen, while no reactions occurred with 20 normal uninfected sera. In the case of vivax malaria, CSP-1 reacted with 128 (80.0%) sera, MSP-1 with 102 (63.8%), AMA-1 with 128 (80.0%), SERA with 115 (71.9%), and EXP-1 with 89 (55.6%), respectively. We obtained higher detection rates when using S antigens (91.9%) rather than using each antigen solely (55.6 - 80%), a combination of 2 (76.3 - 87.5%), 3 (85.6 - 90.6%), or 4 antigens (89.4 - 91.3%). This method can be applied to serological diagnosis, mass screening in endemic regions, or safety test in transfusion of prevalent vivax malaria.

  • PDF

Changing Transmission Pattern of Plasmodium vivax Malaria in the Republic of Korea: Relationship with Climate Change

  • Park, Jae-Won
    • Environmental Analysis Health and Toxicology
    • /
    • 제26권
    • /
    • pp.1.1-1.6
    • /
    • 2011
  • Plasmodium vivax malaria has occurred annually in the Republic of Korea (ROK) since its re-emergence in 1993. P. vivax malaria in ROK has been strongly influenced by infected mosquitoes originating from the Democratic People's Republic of Korea. Korean P. vivax malaria has shown typical characteristics of unstable malaria transmitted only during the summer season, and displays short and long incubation periods. The changing pattern of the transmission period can be predicted by analyzing the seasonal characteristics of early primary attack cases with a short incubation period. Such cases began to gradually occur earlier in the 1990s after the re-emergence. Most of the malaria cases after mid-August are presumed to be early primary attack, short incubation period cases. Only primary transmission was possible until the early 2000s, whereas up to fourth or fifth transmission occurred in the mid-2000s. The results indicate that the length of transmission period has been gradually extending, which may be ascribed to a climate change-mediated temperature rise. Malaria and climate data should be integrated to analyze and predict the influence of climate change on malaria occurrence in ROK.